|
|
Books > Medicine > Other branches of medicine > Pharmacology > General
The large number of new antitumour antibiotics that have been
discovered and evaluated since the first volume of "The Chemistry
of Antitumour Antibiotics" was published in 1978 are described in
this up-to-date work. It covers the results of mode and action
studies which have benefitted from high-field NMR, including 2-D
techniques, computer modelling and DNA sequencing methods. The
volume also notes how biosynthesis has been helped by NMR to follow
the incorporation of compounds containing stable isotopes.
This book provides new structural, biochemical, and clinical
information on ABC transporters. The authors explore and describe
the state of the art of research, knowledge, and prospects for the
future for this important family of proteins. The first ABC
transporter was discovered in 1973 and was named P-glycoprotein. It
elicits resistance to cytotoxic drugs, chiefly in human tumours,
within which chemotherapy failure is observed in about 50% of
cases. Together with its complex pharmacology, and even a suspected
role in Alzheimer's disease, this ABC transporter still eludes a
clinical solution to its multidrug resistance property. ABC
transporters are integral membrane active proteins and they belong
to one of the largest protein families across all species. Their
myriad roles encompass the import or export of a diverse range of
allocrites, including ion, nutrients, peptides, polysaccharides,
lipids, and xenobiotics. They are of major medical importance with
many members elaborating multidrug resistance in bacteria, fungi,
yeast, parasites, and humans. Other ABC transporters are involved
in a number of inherited diseases, including cystic fibrosis,
macular degeneration, gout, and several other metabolic disorders
Zacarias Leon's thesis describes the development and validation of
analytical methods to estimate the processes set in motion by
percutaneous absorption of UV filters in sunscreen cosmetic
products. Leon describes these methods in both in vitro and
non-invasive in vivo methodologies. Currently dermatologists
recommend the use of sunscreen products not only under conditions
of extreme exposure to the sun but also in daily situations.
However the chemical compounds in these products contain may lead
to undesired processes and cause induced toxicity, estrogenic
effects and endocrine activity. Leon establishes methods to
investigate these effects and provides valuable information on the
undesired side effects associated with the use of UV filters found
in sunscreen products. The work in this thesis has led to a number
of publications in renowned analytical chemistry journals.
"Translational Neuroimaging: Tools for CNS Drug Discovery,
Development and Treatment" combines the experience of academic,
clinical and industrial neuroimagers in a unique collaborative
approach to provide an integrated perspective of the use of small
animal and human brain imaging in developing and validating
translational models and biomarkers for the study and treatment of
neuropsychiatric disorders. "Translational Neuroimaging: Tools for
CNS Drug Discovery, Development and Treatment" examines the
translational role of neuroimaging in model development from
preclinical animal models, to human experimental medicine, and
finally to clinical studies. The focus of this book is to identify
and provide common endpoints between species that can serve to
inform both the clinic and the bench with the information needed to
accelerate clinically-effective CNS drug discovery. This book
covers methodical issues in human and animal neuroimaging
translational research as well as detailed applied examples of the
use of neuroimaging in neuropsychiatric disorders and the
development of drugs for their treatment. Offering an accompanying
website with illustrations and text available for further knowledge
and presentations, "Translational Neuroimaging: Tools for CNS Drug
Discovery, Development and Treatment" appeals to non-clinical and
clinical neuroscientists working in and studying neuropsychiatric
disorders and their treatment as well as providing the novice
researcher or researcher outside of his/her expertise the
opportunity to understand the background of translational research
and the use of imaging in this field.
Provides a background to translational research and the use of
brain imaging in neuropsychiatric disordersCritical discussion of
the potential and limitations of neuroimaging as a translational
tool for identifying and validating biomarkersIdentifies cross
species neurosystems and common endpoints necessary to help
accelerate CNS drug discovery and development for the treatment of
neuropsychiatric disordersFeatures an accompanying website with
additional images and text
Obesity is an epidemic with enormous health, economic and social
burdens. Current drugs for obesity treatment are far from ideal in
terms of efficacy and side effects. Reviews in this volume of
Progress in Molecular Biology and Translational Science summarize
current status in studies of a number of G protein-coupled
receptors that were shown to be promising targets for obesity
treatments. Some of these receptors also cause monogenic obesity in
humans.
Subject matter: obesity is an epidemic and G protein-coupled
receptors are promising drug targets, with significant potential as
new anti-obesity drugs.
Chapters are written by leading experts.
This third edition volume expands on the previous editions both by
presenting more detailed protocols for the techniques described in
the first and second editions of High Throughput Screening: Methods
and Protocols and by covering important new procedures. The first
chapter of this book provides an overview of important assay
development techniques, while the rest of the chapters detail how
to develop and execute screens at whatever throughput the user
needs. Some chapter examples are: structure-based virtual
screening, high throughput screening using mass spectrometry,
identification of state-dependent blockers for voltage gated
calcium channels, bioluminescence resonance energy transfer
platform to monitor protein-protein interactions in live cells,
high throughput flow cytometry, and application of imaging-based
assays in microplate formats for high content screening. Written in
the highly successful Methods in Molecular Biology series format,
chapters include introductions to their respective topics, lists of
the necessary materials and reagents, step-by-step, readily
reproducible laboratory protocols, and tips on troubleshooting and
avoiding known pitfalls. Cutting edge and thorough, High Throughput
Screening: Methods and Protocols, Third Edition, is a valuable
resource for anyone who is interested in HTS research.
The concept of immunotherapy was in infancy when the first edition
was written; since then, major advances have been made, not only
with several prominent clinical trials, but also with the approval
of cell-based therapy by the FDA for the treatment of cancer in
2010. These events resulted in a gradually narrowing gap between
early scientific knowledge and the late development of immune-based
therapies. Consequently, the significance and magnitude of these
advances warranted a revision of this contribution; this revised
edition will provide a deeper understanding of the recent advances
and discoveries related to the function of the immune response and
their applications in the development of novel therapies to treat
human diseases. Some of the key discoveries during the past five
years include: the identification of the new subsets of helper T
cells; new cytokines and their networks; and novel signal
transduction mechanisms. For example, the identification of TH17
subset of helper T cells, in addition to TH1 and TH2 cells, not
only advanced our understanding of the function of the basic immune
response, but also raised our awareness of the possible etiology
and pathogenesis of diseases such as allergy, asthma, rheumatoid
arthritis, and other auto-immune/immune system based diseases. The
newly identified powerful cytokine networks, that regulate both
innate and acquired immune responses, emerged as a result of the
finding of new cell types such as innate lymphoid cells and iNKT.
Identification of the novel cytokines and their networks has
advanced our knowledge of the mechanisms involved in the
maintenance of tissue homeostasis, including inflammation and
tissue repair during stress and injury. The development of HIV
vaccines has also seen dramatic changes over the last few years.
There has been a shift from a sole focus on T cell vaccines to a
holistic approach that pertains to the induction of both humoral
and cellular elements. This entails the induction of antibodies -
both binding and neutralizing - to prevent infection. The cellular
vaccination produces a safety net of CD8+ T-cell responses to
suppress the replication of the virus in the infected patients, and
both of the effector arms are aided by helper T cells. From the
perspective of clinical applications, significant advances have
also been made in: oral immunotherapy for allergic disease, the
possible treatment of HIV infection, the development of new
monoclonal antibodies and their fragments to treat human diseases,
and immune cell based therapies for cancer.
This book highlights current Cannabis research: its botany,
authentication, biotechnology, in vitro propagation, chemistry,
cannabinoids biosynthesis, metabolomics, genomics, biomass
production, quality control, and pharmacology. Cannabis sativa L.
(Family: Cannabaceae) is one of the oldest sources of fiber, food
and medicine. This plant has been of interest to researchers,
general public and media not only due to its medicinal properties
but also the controversy surrounding its illicit use. Cannabis has
a long history of medicinal use in the Middle East and Asia, being
first introduced as a medicine in Western Europe in the early 19th
century. Due to its numerous natural constituents, Cannabis is
considered a chemically complex species. It contains a unique class
of terpeno-phenolic compounds (cannabinoids or phytocannabinoids),
which have been extensively studied since the discovery of the
chemical structure of tetrah ydrocannabinol ( 9-THC), commonly
known as THC, the main constituent responsible for the plant's
psychoactive effects. An additionally important cannabinoid of
current interest is Cannabidiol (CBD). There has been a significant
interest in CBD and CBD oil (extract of CBD rich Cannabis) over the
last few years because of its reported activity as an antiepileptic
agent, particularly its potential use in the treatment of
intractable epilepsy in children.
Psychopharmacology is a dominant treatment in child and adolescent
psychiatry with proven benefits to young patients. The authors
present topics related to PSYCHOPHARMACOLOGY ISSUES: Ethical
issues, Treatment planning, Side effects, Neural correlates, and
Pharmacogenomics. They address DRUGS FOR SPECIFIC DISEASES:
Anxiety, Depression, Eating disorders, Sleep disorders, Psychosis
and Schizophrenia, High-risk for bilpolar and schizophrenia,
Bipolar, ADHD, and Autism. Each topic presents an Overview of the
Disease or Issue, Empirical evidence for ethical issues, Treatment
summaries that include dose ranges, side effects,
contraindications, and how the drugs are used specifically for a
disorder. Treatment in the presence of co-morbid conditions,
Long-term evidence, and Conclusions and Future directions complete
the presentations. Clinical vignettes are provided that exemplify
the main points of the topic.
The book will provide an exhaustive and clear explanation of how
Statistics, Mathematics and Informatics have been used in cancer
research, and seeks to help cancer researchers in achieving their
objectives. To do so, state-of-the-art Biostatistics,
Biomathematics and Bioinformatics methods will be described and
discussed in detail through illustrative and capital examples taken
from cancer research work already published. The book will provide
a guide for cancer researchers in using Statistics, Mathematics and
Informatics, clarifying the contribution of these logical sciences
to the study of cancer, thoroughly explaining their procedures and
methods, and providing criteria to their appropriate use.
1. Gene Therapy.- Asthma.- 2. Genetics of Asthma.- 3. Transcription
Factors and Inflammatory Lung Disease.- 4. Regulation of the
Cytokine Gene Cluster on Chromosome 5q.- 5. Cytokine Expression in
Asthma.- 6. ?-Adrenoceptors.- 7. Regulation of Eosinophil
Migration.- 8. Proteinase Allergens of House Dust Mites: Molecular
Biology, Biochemistry and Possible Functional Significance of Their
Enzyme Activity.- Cancer.- 9. Gene Expression in Lung Cancer.- 10.
Gene Therapy for Cancer: Prospects for the Treatment of Lung
Tumours.
"Annual Reports in Medicinal Chemistry "provides timely and
critical reviews of important topics in medicinal chemistry
together with an emphasis on emerging topics in the biological
sciences, which are expected to provide the basis for entirely new
future therapies.
Timely and critical reviews of important topics in medicinal
chemistry
This book brings together reviews from international experts who
are exploring the biological activities of nanomaterials for
medical applications or to better understand nanotoxicity. Topics
include but are not limited to the following: 1) mechanistic
understanding of nanostructure-bioactivity relationships; 2) the
regulation of nanoparticles' bioactivity by means of chemical
modification; 3) the new methodologies and standard methods used to
assess nanoparticles' bioactivity; 4) the mechanisms involved in
nanoparticle-biomolecule interactions and nanoparticle-cell
interactions; and 5) biomedical applications of nanotechnology. The
book will be a valuable resource for a broad readership in various
subfields of chemical science, engineering, biology, environment,
and medicine.
This issue of Endocrinology Clinics brings the reader up do date on
the current standards and important advances in insulin therapy.?
The following clinical topics are discussed: types of insulins,
including new insulins; goals of therapy; pathophysiology of, and
insulin treatment in type1 and type 2 diabetes mellitus; pumps and
glucose sensors; alternative insulin delivery; patient and provider
insulin resistance; inpatient insulin therapy; insulin therapy in
pregnancy; and pediatric insulin therapy.
This new volume of "Advances in Pharmacology" explores the
current concepts in drug metabolism and toxicology. Chapters cover
the Keap1-Nrf2 cell defense pathway, animal models of drug-induced
idiosyncratic toxicity and the use of human embryonic and induced
pluripotent stem cells for modeling metabolism and toxicity. With a
variety of chapters and the best authors in the field, the volume
is an essential resource for pharmacologists, immunologists and
biochemists alike.
Explores the current concepts in drug metabolism and toxicology
Chapters cover such areas as the Keap1-Nrf2 cell defense pathway,
animal models of drug-induced idiosyncratic toxicity and the use of
human embryonic and induced pluripotent stem cells for modeling
metabolism and toxicityAn essential resource for pharmacologists,
immunologists and biochemists alike
"TherapeuticDrug Monitoring: Newer Drugs andBiomarkers"features
timely topics such as the monitoring of classical and newer drugs,
pharmacogenomics and the application of biomarkers in therapeutic
drug monitoring. This reference also discusses the limitations of
current commercially available immunoassays for therapeutic
monitoring. It presentsnew and sophisticated techniques used for
proper determination of blood levels and the clinical utility of
therapeutic drug monitoring of contemporary drugs. Written by
leading international experts and geared toward clinical
pathologists, toxicologists, clinical chemists, laboratory
professionals and physicians, this book is an essential resource on
the current practice of therapeutic drug monitoring in improving
patient safety.
Includes both the technical and clinical issues associated with
therapeutic drug monitoring.
Discusses theutility of therapeutic drug monitoring of newer
drugs such as antiretroviral agents, anticonvulsants,
antidepressants etc.
Provides up-to-date information onissues inpharmacogenomics and
personalized medicine with emphasis on therapy with warfarin,
certain anticancer drugs and antidepressants.
Covers important content on thelimitations of commercially
available immunoassays (chemical tests) for therapeutic drug
monitoring and additional analytical techniques. "
This volume assembles the leading aggression researchers both at
the preclinical and clinical level. They review the current state
of knowledge about neural mechanisms of aggressive behavior and
point to the need for innovative methodologies to further our
understanding of this greatly understudied set of behaviors.
|
|